The discrepancies in the prevalence of diabetes mellitus and cardiovascular disease in individuals with SBMA across studies may also reflect differences in age of study population, genetic background, environmental factors, or methodology but underscore the need for further investigations of the cardiovascular–metabolic risk profile in carriers of all sizes of CAG repeat expansions in the AR gene, including female carriers. This evidence concerns the gene AR and diabetes mellitus.